Bookmark and Share

Last Minute: "Mueller Hearings on Wednesday Present Make-or-Break Moment for Democrats - The New York Times" Sat, 20 Jul 2019 09:00:17 GMT    "Heat wave blazes on: 'It's even too hot for ice cream' - NBC News" Sat, 20 Jul 2019 08:46:00 GMT    "California leads nation -- by far -- in naturalized citizens, data show - Fox News" Sat, 20 Jul 2019 07:14:05 GMT    "Hong Kong?s Approach to Protesters: No More Concessions - The New York Times" Fri, 19 Jul 2019 13:34:18 GMT    "Bernie Sanders defends campaign staff salaries after accusations of 'poverty wages' - Fox News" Sat, 20 Jul 2019 08:21:22 GMT   "Iran's gamble on a tanker seizure will end its credit -- even among friends - CNN" Sat, 20 Jul 2019 08:44:00 GMT    "Awkward exchanges as Trump meets religious persecution survivors ? video - The Guardian" Fri, 19 Jul 2019 04:25:00 GMT    "For ?client? Jeffrey Epstein, an unlocked cell in a Florida jail - The Washington Post" Fri, 19 Jul 2019 22:52:30 GMT    "Is Trump a Racist or a Narcissist? - Slate Magazine" Fri, 19 Jul 2019 23:44:00 GMT    "Sanders unveils plan to guarantee the 'right to a secure retirement' | TheHill - The Hill" Fri, 19 Jul 2019 23:00:12 GMT      For more news, click here.

Authentication
       
       
Remember me? 

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
High46.47Low45.11
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Pfizer -  [Ticker: PFE] chart
Change to Pfizer Interactive Technical Analysis Chart

Last 10 Forum Topics about Pfizer:
No topics about Pfizer [PFE] have been found, but a search on the Forum for more topics related to Pfizer is advised.

 News about Pfizer [PFE]:   (ordered by relevance)
Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals  FiercePharma

Think you're busy? Take a look at Pfizer's commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and ...

Free of Pfizer, AM-Pharma raises ?116M for phase 3  FierceBiotech

AM-Pharma has raised ?116 million ($131 million) to run a pivotal clinical trial in sepsis-associated acute kidney injury. The financing sets AM-Pharma up to ...

Sarepta vs Pfizer: Which Stock Should Investors Buy?  Yahoo Finance

Sarepta Therapeutics, Inc. (SRPT) got a major boost in June after Pfizer, Inc. (PFE) presented data on its new Duchenne Muscular Dystrophy (DMD) gene ...

Pfizer donates fun kits for kids in the ER  theday.com

Pfizer Inc. on July 2 delivered 1,000 individually boxed ?Pediatric Fun Kits? to help comfort children who are in the emergency room at Lawrence + Memorial ...

Pfizer Canada to manage EpiPen distribution ahead of possible shortage  Seeking Alpha

As a precautionary measure to assure supply, Pfizer Canada (PFE), the manufacturer of Mylan's (MYL +0.9%) emergency allergic reaction med EpiPen ...

Pfizer (PFE) Gains As Market Dips: What You Should Know  Yahoo Finance

Pfizer (PFE) closed at $42.86 in the latest trading session, marking a +0.25% move from the prior day.

Federal judge will allow consumer fraud claim to continue vs Pfizer over Robitussin labeling  Cook County Record

A federal judge has again rejected pharmaceutical maker Pfizer's request to end a potential consumer fraud class action over the labeling of its Robitussin ...

Pfizer Hid Risks Of Sepsis, Amputation On Labels, Suit Says  Law360

An Arkansas woman sued Pfizer Inc. on Thursday, saying the company failed to warn U.S. customers that an arthritis drug can cause sepsis, resulting in the ...

Do Institutions Own Shares In Pfizer Inc. (NYSE:PFE)?  Yahoo Finance

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Every investor in Pfizer Inc.

Acquisition Improves the Outlook of Pfizer Stock  Yahoo Finance

Pfizer (NYSE: PFE) stock has enjoyed an uptrend that started in late April. With an upcoming quarterly dividend of 36 cents, giving Pfizer stock a yield of 3.3%, ...

Investor lawsuit seeks to stop $11.4B merger of Pfizer and Boulder-based Array BioPharma  Boulder Daily Camera

An investor in Boulder-based Array BioPharma on Thursday filed a lawsuit against the company alleging it failed to provide shareholders key information ...

Pfizer Pearl River Staffers Participate in AIDS Walk New York??  Pearl River, NY Patch

Pfizer Pearl River Staffers In AIDS Walk NY - Pearl River, NY - The Pfizer team joined more than 15000 others to raise more than $4 million for dozens of AIDS ...

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas  Yahoo Finance

For Immediate Release. Chicago, IL ? July 17, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...

Pfizer (PFE) Flat As Market Sinks: What You Should Know  Yahoo Finance

In the latest trading session, Pfizer (PFE) closed at $43.76, marking no change from the previous day.

New Alnylam Pharmaceuticals CFO Faces Competition Challenge With Pfizer  Wall Street Journal

Alnylam Pharmaceuticals Inc. named a new finance chief, a move that comes as the biopharmaceutical company faces new competition from drug giant Pfizer ...

EU OKs Glaxo buy of Pfizer unit, with conditions  MarketWatch

European Union antitrust authorities conditionally approved late Wednesday the acquisition by GlaxoSmithKline PLC (GSK.LN) of Pfizer Inc.'s PFE consumer...

Better Buy: Pfizer vs. Johnson & Johnson  The Motley Fool

Which of these pharmaceutical giants is best positioned to help your portfolio grow?

Pfizer Purchase of Array BioPharma Looks Smart After New Drug Trial Results  Barron's

New results from a colorectal cancer study by Array BioPharma seem to validate Pfizer's decision last month to acquire the drug company for $10.6 billion.

Pfizer Inc. [PFE] ? 3 compelling analyses why it's a less risky Investment  The Dwinnex

Pfizer Inc. [PFE] saw a change by 0.75% with the Thursday trading session, closing the trade at the price of $43.06. The company is holding 5.70B shares with ...

Pfizer gene therapy for rare muscle disease shows promise in small, early study  Yahoo Finance

Pfizer Inc on Friday presented promising results from a tiny early study of its experimental gene therapy for a rare muscle disease, but two of the six patients in ...

Former FDA head Gottlieb joins Pfizer board  Washington Post

Scott Gottlieb, the former Food and Drug Administration commissioner who left the agency earlier this year, is joining the board of directors of pharmaceutical ...

Elizabeth Warren Calls on Former F.D.A. Chief to Quit Pfizer Board  The New York Times

Senator Elizabeth Warren on Tuesday called on Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, to resign from the board of ...

SNY or PFE: Which Is the Better Value Stock Right Now?  Yahoo Finance

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Sanofi (SNY) and Pfizer (PFE). But which of these two ...

Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study  MarketWatch

Shares of Pfizer Inc. ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in ...

Array pushed Pfizer for a higher price to get deal done  BioPharma Dive

Array BioPharma's board rejected an initial $44-per-share buyout offer Pfizer made on May 29, saying it was too low for Array to commit to the June 17 ...

Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway  Yahoo Finance

Some investing decisions seem like no-brainers. If you know that a company's sales growth is about to evaporate, staying away from the stock makes a lot of ...

Top Research Reports for Berkshire Hathaway, Pfizer & Danaher  Nasdaq

Tuesday, July 16, 2019. The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports ...

Gene therapy for hemophilia from Pfizer and Sangamo shows promise  STAT

The new data are early, but point to a possible future in which patients might have a handful of curative options for the rare bleeding disorder.

Pfizer (PFE) Gains But Lags Market: What You Should Know  Nasdaq

In the latest trading session, Pfizer (PFE) closed at $44.40, marking a +0.41% move from the previous day. The stock lagged the S&P 500's daily.

Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval  Yahoo Finance

Pfizer, Inc. PFE announced that the FDA has granted approval to Zirabev, its biosimilar version of Roche's RHHBY blockbuster cancer drug, Avastin for several ...

Array's colorectal cancer data shows why Pfizer splashed out $11B for the biotech  FiercePharma

Key to Pfizer's paying $11 billion for Array BioPharma were the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown ...

Pfizer's Talzenna Gets Approval in Europe for Breast Cancer  Yahoo Finance

Pfizer Inc. PFE announced that the European Commission has approved its PARP inhibitor, Talzenna (talazoparib) for BRCA-mutated advanced breast cancer ...

Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs  Yahoo Finance

This week, there were several pipeline and regulatory updates from Pfizer PFE. Meanwhile, the Committee for Medicinal Products for Human Use (?CHMP?) of ...

Pfizer, with hopeful results, leaps into race for a Duchenne gene therapy  STAT

The company's gene therapy appeared to help children with the condition, but its side effects were severe in some clinical trial participants.

Sarepta Therapeutics Stock Could Capitalize From Pfizer?s Stumble  Barron's

Sarepta Therapeutics stock boomed on Friday, up 17% after Pfizer announced data on its gene therapy for Duchenne muscular dystrophy, DMD, that appeared ...

Pfizer Completes Acquisition of Therachon  Business Wire

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therac.

Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod  Yahoo Finance

This week Pfizer PFE announced a definitive deal to buy Array BioPharma to strengthen its cancer portfolio. In other news, Merck's MRK blockbuster PD-L1 ...

Pfizer, Sanofi, to boost South African Biovac's vaccine output  Reuters

CAPE TOWN (Reuters) - South Africa's Biovac Institute will start local production of Sanofi's Hexaxim vaccine next year and Pfizer's anti-pneumonia Prevnar 13 ...

Is Pfizer Overpaying for Array Biopharma?  The Motley Fool

When Pfizer (NYSE:PFE) opened up its checkbook this week to buy Array Biopharma (NASDAQ:ARRY), it was bidding for a small cancer portfolio that has big ...

NICE shuts down AZ's Tagrisso?and backs Pfizer rival Vizimpro instead  FiercePharma

England's cost watchdogs won't get behind AstraZeneca blockbuster Tagrisso in previously untreated patients with EGFR-mutated lung cancer. But in a change ...

Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015  TheStreet.com

There's much concern over the hefty price that AbbVie (ABBV) has agreed to pay for struggling pharmaceutical company Allergan (AGN) -- but in the context of ...

Pfizer says FDA has approved its oncology biosimilar Zirabev to treat 5 types of cancer  MarketWatch

Pfizer Inc. said Friday the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer. The FDA...

Former Pfizer site in Puerto Rico picked up by medical marijuana producer  FiercePharma

Looks like unloading surplus manufacturing sites to the cannabis industry is turning into a budding business for pharma. At the same time Novartis was ...

Pfizer Declares Third-Quarter 2019 Dividend  Yahoo Finance

The Board of Directors of Pfizer Inc. today declared a 36-cent third-quarter 2019 dividend on the company's common stock, payable September 3, 2019, ...

Pfizer working with Finnish tech startup to improve patient adherence  MobiHealthNews

Only around 50% of patients with long-term illnesses adhere to their treatment, according to the World Health Organization (WHO). To help combat this, ...

EU greenlights GSK-Pfizer joint venture  Yahoo News

Brussels (AFP) - The EU on Wednesday approved the merger of the consumer healthcare activities of pharmaceutical giants GlaxoSmithKline and Pfizer that ...

Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma  Yahoo Finance

The index enjoyed another week of strong gains after the Federal Reserve indicated that a rate cut would likely occur next month.

Sarepta Stock Faces 'Whale' Of A Challenge As Pfizer Set To Unveil Gene Therapy Data  Investor's Business Daily

Sarepta stock will face a "whale" of an overhang Friday when Pfizer unveils the results of its gene therapy in Duchenne muscular dystrophy, an analyst says.

Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency  PRNewswire

CAMBRIDGE, Mass., June 26, 2019 /PRNewswire/ -- Pfizer Inc. opens a call for interested U.S. startup companies to submit non-confidential proposals for a ...

Was Pfizer?s Refusal to Pursue Promising Alzheimer?s Drug Based on Finances?  Citizen Truth

Was Pfizer's decision not to pursue Enbrel as an Alzheimer's drug purely based on science, or was it based on the almighty dollar? Pfizer is highly regarded for ...

Sangamo's Hemophilia A Results Light A Spark And Push Program Into Pfizer's Hands  Seeking Alpha

Sangamo Therapeutics reports positive results from its phase 1/2 open-label study using SB-525 to treat patients with Hemophilia A. The global hemophilia ...

Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know  Nasdaq

Pfizer (PFE) closed at $43.37 in the latest trading session, marking a +0.16% move from the prior day. This move outpaced the S&P 500's daily.

Sarepta Soars As Pfizer's DMD Prospects Languish  Seeking Alpha

Pfizer's recent PPMD conference revealed very concerning safety issues with its gene therapy candidate for DMD. Pfizer's candidate might be headed down ...

Pfizer successfully completes the acquisition of Therachon  European Pharmaceutical Review

Pharmaceutical company, Pfizer, has announced it has successfully completed the acquisition of Therachon for $340 million.

Comparing PFE's and BMY's Immunology Drugs  Market Realist

Pfizer's (PFE) commercialized JAK (Janus kinase) inhibitor, Xeljanz, is approved for treating rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Athena Capital Advisors Decreased Amazon Com (AMZN) Holding by $665620; As Pfizer (PFE) Stock Declined, Bell State Bank & Trust Lowered Stake  The InvestReporter

Athena Capital Advisors Llc decreased its stake in Amazon Com Inc (AMZN) by 52.15% based on its latest 2019Q1 regulatory filing with the SEC. Athena Capital ...

Ex-FDA director Gottlieb joins Pfizer  The Columbian

Scott Gottlieb, the former Food and Drug Administration commissioner who left the agency earlier this year, is joining the board of directors of pharmaceutical ...

Pfizer Inc. (PFE) vs. At Plexus Corp. (PLXS): Analyzing the Industry?s Most Active Stocks  E Globalist

The shares of Pfizer Inc. have decreased by more than -1.35% this year alone. The shares recently went up by 0.75% or $0.32 and now trades at $43.06.

Scoring Pfizer v Sarepta: This round on Duchenne gene therapy goes to the little biotech, but the pharma Goliath has plenty of punch left  Endpoints News

Unlock this story instantly and join 55,000+ biopharma pros reading Endpoints daily ? and it's free. SUBSCRIBE SIGN IN. Francesco De Rubertis. July 18, 2019 ...

Why Putting the Former Head of the FDA On Pfizer?s Board Is So Fraught  Yahoo Finance

Two months after stepping down as the head of the Food and Drug Administration, Scott Gottlieb has quietly taken a seat on the board of Pfizer. Now Democratic ...

Pfizer Reports Failure in Persistent Pulmonary Hypertension, Progress in Duchenne Muscular Dystrophy  BioSpace

Pfizer's intravenous (IV) Revatio (sildenafil), when added to inhaled nitric oxide (iNO), failed to meet its primary efficacy endpoint in treating newborns with ...

GSK-Pfizer joint venture gets conditional approval from South Africa's competition regulator  Reuters

GlaxoSmithKline Plc and Pfizer Inc's planned joint venture received conditional approval from a South African regulator on Tuesday, clearing a hurdle in the ...

Somerville Kurt F Decreased Pfizer (PFE) Holding by $360150; Stock Value Declined; Spectrum Asset Management Nb Lifted Its Intel (INTC) Position  The InvestReporter

Somerville Kurt F decreased its stake in Pfizer (PFE) by 22.6% based on its latest 2019Q1 regulatory filing with the SEC. Somerville Kurt F sold 8575 shares ...

GSK preps for Pfizer consumer health JV with £1B in product sell-offs: report  FiercePharma

GlaxoSmithKline has reportedly started selling off some non-core consumer products as it looks to raise £1 billion to cover the costs of a Pfizer OTC merger.

Golin hires Pfizer vet Rachel Hooper as healthcare media relations lead - People Moves - MM&M  Medical Marketing and Media

NEW YORK: Golin has hired Pfizer veteran Rachel Hooper to lead healthcare media relations for the firm. Hooper reports to Golin's global president of ...

What's driving the Anophthalmia and Microphthalmia Market| Pfizer, Bristol-Myers Squibb, Shire  US Trade Media

The Global Anophthalmia and Microphthalmia Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released by Data Bridge Market ...

Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN  Nasdaq

Top Health Care Stocks: JNJ: -0.05% PFE: +0.21% ABT: +0.27% MRK: +0.36% AMGN: +0.45% Health care majors were mostly higher in Friday's pre-bell.

Atopic Dermatitis Market Forecast Period 2019-2026: Velite Pharmaceuticals, Galderma SA, Pfizer Inc, Fujisawa  Herald Correspondent

Global Atopic Dermatitis Market By Mechanism of Action Type (Antihistamines, Topical corticosteroids, Emollients, Phosphodieterase-4 (PDE-4) inhibitor, ...

As Pfizer Com (PFE) Market Value Declined, Holder Live Your Vision Has Upped Its Holding; Forward Management Has Upped Holding in Brookfield Ppty Partners LP (BPY) by $1.61 Million as Valuation Declined  The InvestReporter

Live Your Vision Llc increased its stake in Pfizer Inc Com (PFE) by 306.16% based on its latest 2019Q1 regulatory filing with the SEC. Live Your Vision Llc ...

GlaxoSmithKline begins marketing overhaul amid Pfizer merger  The Drum

GlaxoSmithKline Consumer Healthcare is to restructure its media, marketing and digital units in anticipation of the upcoming mega-merger with fellow pharma ...

PFIZER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE  Business Wire

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (?KSF?), announces that KSF.

Copycats wanted: Pfizer, AZ and more under threat as China solicits generics  FiercePharma

The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling ...

Pfizer Inc (NYSE:PFE) Institutional Investor Positioning Change  The MAK Daily

Pfizer Inc (NYSE:PFE) institutional sentiment increased to 0.76 in 2019 Q1. Its up 0.02, from 0.74 in 2018Q4. The ratio increased, as 626 investment ...

Pfizer's Xeljanz drops off top June TV spenders list?and Gilead's Biktarvy fills the void  FiercePharma

AbbVie remained the top pharma TV ad spender with Humira in June, and Gilead Sciences continued its TV push for Biktarvy and Truvada. But one longtime list ...

UnitedHealth and one other Dow stock could be on the cusp of a comeback  CNBC

As the Dow closes in on records, just four stocks have been shut out of the rally. Some could be on the verge of a major breakout.

Farmers & Merchants Investments Has Upped Pfizer (PFE) Stake; As Integrated Device Technology (IDTI) Valuation Were Volatile, Alpine Associates Management Has Upped Stake by $37.81 Million  The InvestReporter

Farmers & Merchants Investments Inc increased its stake in Pfizer Inc (PFE) by 4.31% based on its latest 2019Q1 regulatory filing with the SEC. Farmers ...

Pfizer to invest £5M in paediatric medicines  PharmaTimes

Pfizer has announced the investment of £5 million to grow its manufacturing capabilities for paediatric medicines at its Discovery Park site in Sandwich, Kent.

ERS mounts aggressive effort in redeveloping Pfizer property  Plattsburgh Press Republican

Developer says talks ongoing even as demolition continues.

Pfizer (PFE) Holding Held by Capital International Ltd; Campbell Newman Asset Management Decreased Exxonmobil Corp. (XOM) Holding by $321520; Valuation Rose  The InvestReporter

Capital International Ltd increased its stake in Pfizer Inc (PFE) by 25.99% based on its latest 2019Q1 regulatory filing with the SEC. Capital International ...

Werlin: Pfizer set to purchase cancer drug maker Array BioPharma  Sarasota Herald-Tribune

Pfizer will purchase Array BioPharma for $10.4 billion. It hopes to expand its cancer portfolio with targeted therapies. This acquisition underscores the ...

Pfizer (PFE) Holder Bowen Hanes & Co Has Decreased Holding by $644406 as Valuation Declined; Leavell Investment Management Has Raised Its Position in Blackstone Group LP (BX) by $1.03 Million  The InvestReporter

Bowen Hanes & Co Inc decreased its stake in Pfizer (PFE) by 16.82% based on its latest 2019Q1 regulatory filing with the SEC. Bowen Hanes & Co Inc sold ...

As Pfizer (PFE) Stock Price Declined, Shareholder Knott David M Has Lowered Its Stake; As Amgen (AMGN) Valuation Declined, Cypress Capital Group Has Cut Its Position  The InvestReporter

Knott David M decreased its stake in Pfizer Inc. (PFE) by 60.14% based on its latest 2019Q1 regulatory filing with the SEC. Knott David M sold 218,778 shares as ...

Hamlin Capital Management Has Cut Its Pfizer (PFE) Stake; Array Biopharma (ARRY) Has 1.66 Sentiment  The InvestReporter

Hamlin Capital Management Llc decreased Pfizer Inc (PFE) stake by 3.43% reported in 2019Q1 SEC filing. Hamlin Capital Management Llc sold 79734 shares ...

New data boost Pfizer, Sangamo hemophilia A gene therapy  FierceBiotech

Pfizer and Sangamo Therapeutics have shared an upbeat update on their hemophilia A gene therapy. The update features evidence of the durability of ...

Pfizer staff face crunch vote on pensions  The Irish Times

WRC awaits outcome of ballots on improved proposals to surrender final salary scheme.

Musculoskeletal Disorders Drugs Market 2019 Current and Future Growth Analysis | Pfizer Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Eli Lilly  Pledge Times

Global Info Reports recently published a detailed study of 'Musculoskeletal Disorders Drugs' market covering interesting aspects with supporting development ...

Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension  Yahoo Finance

Pfizer Inc. (PFE) announced today that a Phase 3 study to assess the efficacy and safety of intravenous (IV) sildenafil when added to inhaled nitric oxide (iNO) for ...

Pfizer Com (PFE) Holding Has Lifted by Live Your Vision Llc; As Apollo Global Mgmt (APO) Market Value Rose, Mckinley Capital Management Cut Position  The InvestReporter

Live Your Vision Llc increased its stake in Pfizer Inc Com (PFE) by 306.16% based on its latest 2019Q1 regulatory filing with the SEC. Live Your Vision Llc ...

Information Update - Pfizer Canada is reporting a shortage of EpiPen (0.3 mg) auto-injectors and taking precautions to minimize impact on Canadians  BioSpace

OTTAWA, July 19, 2019 /CNW/ - Pfizer Canada is reporting that, while there has been stable supply of EpiPen auto-injectors in Canada in 2019 to date, ...

Foundation Resource Management Has Trimmed Holding in Pfizer (PFE) by $838152; Sherwin Williams Co (Call) (SHW) Stake Raised by Citadel Advisors Llc  The InvestReporter

Foundation Resource Management Inc decreased its stake in Pfizer (PFE) by 3.71% based on its latest 2019Q1 regulatory filing with the SEC. Foundation ...

Recon: J&J Returns Rights to Hanmi Diabetes Drug; NICE Backs Pfizer's Vizimpro  Regulatory Focus

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Trump Says 'Favored Nations' Drug Plan Would ...

Pfizer Ltd. - Shareholding for the Period Ended June 30, 2019  The Hindu BusinessLine

Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here Source : BSE ...

Equinix (EQIX) Holding Upped by Utah Retirement Systems; As Pfizer (PFE) Stock Price Declined, Oakworth Capital Has Decreased Stake by $776916  The InvestReporter

Utah Retirement Systems increased its stake in Equinix Inc (EQIX) by 7.12% based on its latest 2019Q1 regulatory filing with the SEC. Utah Retirement Systems ...

Demolition ramps up on old Pfizer plant  WPTZ

Construction on the old Pfizer plant in Rouses Point has been ramping up the past couple of months. One of the partners in the project, CDC Real Estate, ...

Stye Drug Market - Pfizer Inc, XOMA, EyePoint Pharmaceuticals, Enzo Biochem Inc., AbbVie Inc, TopiVert Ltd, Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals Inc  US Trade Media

A superior and comprehensive market research report endows professionals with a lot of aspects about the market and the industry. The Stye Drug report ...

Disruptive Behavior Disorder Dbd Treatment Market :- Top Leading Players are Pfizer Inc., Johnson & Johnson Services, Inc., Bionomics, Highland Ridge Hospital  US Trade Media

This Disruptive Behavior Disorder Dbd Treatment market report highlights key market dynamics of Medical Devices industry and covers historic data, present ...

Global Antibody Drug Conjugates Market 2019-2025 Novartis AG, Takeda Pharmaceutical, Pfizer, Seattle Genetics  Market Analyst

Global Antibody Drug Conjugates Market 2019-2025 investigated the popular scenario within the descriptions, arrangements, applications, and business chain ...

BioMarin Earns Milestone Payments from Pfizer for TALZENNA® (talazoparib) for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation  PRNewswire

SAN RAFAEL, Calif., June 21, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the Company earned a $15 million ...

Congenital Heart Diseases Market Future Scope and Growth Factors 2019 ? 2025| Pfizer, Abbott Laboratories, Eli Lilly, Ranbaxy Pharmaceutical  Top News Desk

Los Angeles, United State, July 19, 2019, ? The latest report published by QY Research presents a thorough analysis of the global Congenital Heart Diseases ...

Strategic Report on High Viscosity Tissue Adhesives Market with Top Key Players- Pfizer, Inc., Johnson, and  Rise Media

?Market Synopsis :- High viscosity tissue adhesives are used mainly for closure of wounds, injuries or traumas and post-operative incisions. High viscosity tissue ...

For more news about Pfizer click here:
Pfizer News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2019 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources